Drug Patent Expirations in April 2015

Drug Patent Expirations for April 2015

TradenameApplicantGeneric NamePatent NumberPatent Expiration
FAMVIRNovartisfamciclovir6,124,304*PEDApr 4, 2015
FAMVIRNovartisfamciclovir5,866,581*PEDApr 4, 2015
PROVIGILCephalonmodafinilRE37516*PEDApr 6, 2015
NUVIGILCephalonarmodafinilRE37516*PEDApr 6, 2015
ADVAIR HFAGlaxo Grp Ltdfluticasone propionate; salmeterol xinafoate5,674,472*PEDApr 7, 2015
HYCAMTINGlaxosmithklinetopotecan hydrochloride5,674,872*PEDApr 7, 2015
FLOVENT HFAGlaxo Grp Ltdfluticasone propionate5,674,472*PEDApr 7, 2015
AKYNZEOHelsinn Hlthcarenetupitant; palonosetron hydrochloride5,202,333Apr 13, 2015
ALOXIHelsinn Hlthcarepalonosetron hydrochloride5,202,333Apr 13, 2015
JUXTAPIDAegerionlomitapide mesylate5,739,135Apr 14, 2015
MYLOTARGWyeth Pharms Incgemtuzumab ozogamicin5,739,116Apr 14, 2015
GATTEX KITNps Pharms Incteduglutide recombinant5,789,379Apr 14, 2015
CLEVIPREXMedicines Coclevidipine5,739,152Apr 14, 2015
EMENDMerckaprepitant5,719,147Apr 17, 2015
ABILIFY MAINTENA KITOtsuka Pharm Co Ltdaripiprazole5,006,528Apr 20, 2015
ABILIFYOtsukaaripiprazole5,006,528*PEDApr 20, 2015
CAVERJECTPharmacia And Upjohnalprostadil5,741,523Apr 21, 2015
EXUBERAPfizerinsulin recombinant human5,740,794Apr 21, 2015
OXYTROLWatson Labs (utah)oxybutynin5,601,839Apr 26, 2015
OXYTROL FOR WOMENBayer Healthcare Llcoxybutynin5,601,839Apr 26, 2015
OXYTROLWatson Labs (utah)oxybutynin5,834,010Apr 26, 2015
OXYTROL FOR WOMENBayer Healthcare Llcoxybutynin5,834,010Apr 26, 2015
LAMISILNovartisterbinafine5,681,849*PEDApr 28, 2015
MAVIKAbbvietrandolapril5,744,496Apr 28, 2015
LAMISIL ATNovartisterbinafine5,681,849*PEDApr 28, 2015
LAMISIL ATNovartisterbinafine hydrochloride5,681,849*PEDApr 28, 2015
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: